.bdt-divider-icon{--wpr-bg-f8569bb1-1548-4df8-a5b8-d355394e3d72: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/divider-icon.svg');}.bdt-list-bullet>::before{--wpr-bg-b263c723-9841-4607-bbb0-11af9220d04c: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/list-bullet.svg');}.bdt-input[list]:hover,.bdt-input[list]:focus{--wpr-bg-ae1f03f0-c2f2-49c6-a52f-7f16a8f6ba1c: url('https://mestastop.com/wp-content/plugins/bdthemes-prime-slider-lite/images/backgrounds/form-datalist.svg');}.everest-forms .blockUI.blockOverlay::before{--wpr-bg-418221c8-0b3f-414e-8cb5-252f72b1c8ca: url('https://mestastop.com/wp-content/plugins/everest-forms/assets/images/icons/loader.svg');}.everest-forms .loader::before{--wpr-bg-6e5d5528-b945-4297-8fea-95609c5f4f26: url('https://mestastop.com/wp-content/plugins/everest-forms/assets/images/icons/loader.svg');}.lg-outer .lg-item{--wpr-bg-e926890a-164e-4316-9849-b6a79c3591c5: url('https://mestastop.com/wp-content/themes/onepress/assets/images/loading.gif');}.elementor-2693 .elementor-element.elementor-element-288a1a1:not(.elementor-motion-effects-element-type-background), .elementor-2693 .elementor-element.elementor-element-288a1a1 > .elementor-motion-effects-container > .elementor-motion-effects-layer{--wpr-bg-0b4584c2-1d1d-43bc-8138-edee95e9f452: url('https://tachomind.com/demo/mestastopdev/wp-content/uploads/2023/11/banneror.jpg');}table.dataTable thead .sorting{--wpr-bg-ac923f8a-8a36-4c89-8050-d6898d7b81e8: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/arrow.png');}table.dataTable thead .sorting_asc{--wpr-bg-50421ed6-bb6a-46a9-bcf4-26d152a38756: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_asc.png');}table.dataTable thead .sorting_desc{--wpr-bg-b6a92daf-8812-47f5-8d4b-ed012f894600: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_desc.png');}table.dataTable thead .sorting_asc_disabled{--wpr-bg-aeea1875-ee18-48a8-ad7d-4a4adc71c6b3: url('https://mestastop.com/wp-content/plugins/elementskit-lite/widgets/init/assets/img/sort_asc_disabled.png');}

Blog

Mestastop enters into a partnership agreement with Syngene

Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its...

Mestastop enters into a partnership agreement with Syngene

Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its...

Mestastop Partners with Peptris to Repurpose Approved Drugs for Cancer Metastasis

Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its...

Mestastop Partners with Peptris to Repurpose Approved Drugs for Cancer Metastasis

Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its...

Mestastop starts their AI/ML journey

Mestastop Solutions have appointed Ankesh Khemani, as an Advisor for “Data Strategy...

Mestastop starts their AI/ML journey

Mestastop Solutions have appointed Ankesh Khemani, as an Advisor for “Data Strategy...

Mestastop raises funding from Vistari Venture Partners

Mestastop Solutions have raised a third successive round of funding against Compulsorily C...

Mestastop raises funding from Vistari Venture Partners

Mestastop Solutions have raised a third successive round of funding against Compulsorily C...

Mestastop is on @Science Exchange

Mestastop Solutions have partnered with Science Exchange, the globally recognized and resp...

Mestastop is on @Science Exchange

Mestastop Solutions have partnered with Science Exchange, the globally recognized and resp...

Mestastop collaborates with ImmunoBiome Inc., to develop proprietary metastasis animal models

Mestastop, a two-year-old cancer metastasis focused biotech start up based at Bangalore, I...

Mestastop collaborates with ImmunoBiome Inc., to develop proprietary metastasis animal models

Mestastop, a two-year-old cancer metastasis focused biotech start up based at Bangalore, I...